PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon

Similar documents
PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION

ab Complex II Enzyme Activity Microplate Assay Kit

Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit

ab ATP Synthase Enzyme Activity Microplate Assay Kit

ABIOpure TM Total RNA (version 2.0)

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent

For the quantitative measurement of ATP Synthase Specific activity in samples from Human, Rat and Cow

ab MitoTox Complex I OXPHOS Activity Microplate Assay

20X Buffer (Tube1) 96-well microplate (12 strips) 1

Frequently Asked Questions: IS RT-Q-PCR Testing

Metabolism: Oxidative Phosphorylation

For Research Use Only Ver

ab Aconitase Enzyme Activity Microplate Assay Kit

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

Aconitase Enzyme Activity Microplate Assay Kit

A Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs

Test 3 Study Guide: Photosynthesis, Respiration, and the Cell Membrane

The demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY

Completing the NPA online Patient Safety Incident Report form: 2016

Mitosis and Meiosis Lecture Notes

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Module 3. Chapter 5 Microbial Metabolism. Catabolic and Anabolic Reactions Metabolism Two general types of metabolic reactions: o :

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Cancer Immunology, Immunotherapy (submitted in 2014) Christian Krug et al.

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised:

Use of Alkaline Phosphatase for the Analysis of Tannins in Grapes and Red Wines

Finding the right 90 people in 90 days and what to do with them:

INTRODUCTION TO THE CIRCULATORY SYSTEM

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Monensin and Extruded Urea-Grain for Range Beef Cows

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

Action plan: serialisation of Nordic packages focus on Product Codes

BRCA1 and BRCA2 Mutations

Chem 464 Biochemistry Third Hour Exam

REVISION: PHOTOSYNTHESIS & CELLULAR RESPIRATION 18 JUNE 2014

Record of Revisions to Patient Tracking Spreadsheet Template

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health

Pain relief after surgery

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.

H1N1 Influenza 09 Guidance for Residential Aged Care

(From the Laboratories of the International Health Division of The Rockefeller Foundation, New York)

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Tick fever is a cattle disease caused by any one of the following blood parasites:

Post Distribution Monitoring Report

Meaningful Use Roadmap Stage Edition Eligible Hospitals

Initial Postoperative Knee Care Patella or Quadriceps Tendon Repairs: - Videos are available on Dr. Witty s website: drjeffreywitty.

METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY

Triumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media

EMC believes the information in this publication is accurate as of its publication date. The information is subject to change without notice.

Topic 1: Cell Biology (Student) Essential Idea: Eukaryotes have a much more complex cell structure that prokaryotes.

Roche Modular Auto-Verification Settings Guidelines

SQA-VISION VALIDATION REPORT

Statement of Work for Linked Data Consulting Services

Effect of Stage of Maturity on the Chemical Composition and In Vitro Digestibility of Sorghum Grain

Referral Criteria: Inflammation of the Spine Feb

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

THE SORPTION OF INFLUENZA VIRUS BY CHICKEN ERYTHROCYTES*

Swindon Joint Strategic Needs Assessment Bulletin

ab Human Citrate Synthase (CS) Activity Assay Kit

If, then. Homework: Finish entire guided notes packet. Name: Pod: Date: Which variable does a scientist manipulate or control in an experiment?

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

HIV Diagnostic Tests. HIV Testing Algorithm at SydPath (National Reference Laboratory)

1.6. Topic 1: Cell Biology (Teacher) Essential Idea: Cell division is essential but must be controlled. 1.6 Cell Division

How to become an AME Online

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair:

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

Percutaneous Nephrolithotomy (PCNL)

How to Get Set Up and Running with NDepend

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

HPV VACCINATION IN SANDYFORD SERVICES

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

FDA Dietary Supplement cgmp

CDC Influenza Division Key Points November 7, 2014

Measurement of PDH Endogenous Activity Relative to the Fully- States

Commissioning Policy: South Warwickshire CCG (SWCCG)

Annex III. Amendments to relevant sections of the Product Information

Code of employment practice on infant feeding

MitoCheck Complex II Activity Assay Kit

Name: Date: Period: Notes: The Blood and Lymphatic System

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Recommendations for Risk Management at Swine Exhibitions and for Show Pigs August 2012

Chapter 14 Cell division: Continuity of Life means all life originates from other living things of the same type.


Call for evidence on the use of skin sensitisers, skin irritants and corrosive substances in textile and leather articles, hides and furs

Appendix C Guidelines for treating status epilepticus in adults and children

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium

Pediatric and adolescent preventive care and HEDIS *

Measurement of Renin Activity in Human Plasma

Anemia. There are three types of Anemia that effect EB patients. They are Iron Deficiency, Chronic Inflammatory and Nutritional.

FUNCTIONAL MOVEMENT SYSTEMS SCREEN FINDINGS REPORT

PACT premier TM HT-96 MD1-36 PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen.

PILI Lifestyle Program Facilitator s Guide

M.J. Guthriel, D.G. Wagner2

I am having a Rotator Cuff Repair

Cellular Respiration: Harvesting Chemical Energy

Transcription:

PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided fr ne 96-well micrplate. Kit Cntents: Item MS241 20X Buffer 15 ml 10X Detergent 2 x 1 ml 10X Blcking Slutin 5 ml Cmplex II Activity Buffer 25 ml DCPIP 250 µl Succinate 500 µl Ubiquinne 2 60 µl Lipid Mix 6 ml Pre-cated 96-well micrplate (12 strips) 1 INTRODUCTION Cmplex II, als knwn as succinate-cenzyme Q reductase (SDH, EC 1.3.5.1), is ne f the five cmplexes invlved in xidative phsphrylatin in the inner mitchndrial membrane and als a member f the tricarbxylic acid cycle (TCA). It catalyzes electrn transfer frm succinate t the electrn carrier, ubiquinne, but unlike the ther fur cmplexes it is nt a prtn pump. The prduct ubiquinl is utilized by cmplex III in the respiratry chain and the prduct fumarate is necessary t maintain the TCA cycle. Succinate + ubiquinne (Q) Fumarate + ubiquinl (QH 2 ) The Cmplex II Enzyme Activity Micrplate Assay (MS241) is designed fr determining the Cmplex II activity in a sample. Each f the 96 wells in the kit has been cated with an anti-cmplex II mnclnal antibdy (mab) which purifies the enzyme frm a cmplex sample such as mitchndria, tissue hmgenate r cell lysate. After this in-well purificatin the prductin f ubiquinl by the enzyme is cupled t the reductin f the dye DCPIP (2,6-diclrphenlindphenl) and a decreases in its absrbance at 600 nm which in turn recycles the substrate ubiquinne, as shwn belw. ubiquinl (QH 2 ) + DCPIP ubiquinne (Q) + DCPIPH 2 blue clrless

Nte: This prtcl cntains detailed steps fr measuring Cmplex II activity. Be cmpletely familiar with the prtcl and the Ntes sectin (page 9) befre beginning the assay. D nt deviate frm the specified prtcl steps r ptimal results may nt be btained. The prtcl has 3 steps: A. Sample preparatin B. Plate lading C. Measurement This micrplate assay (Catalg # MS241) has been develped fr use with human samples. Hwever, the kit als wrks with bvine, muse and rat samples. Other species are untested at this time. This assay is designed fr use with hmgenates frm cultured cells, and islated mitchndria - tissue lysates can als be used but sme sample ptimizatin may be necessary. As described belw, hmgenized samples shuld be resuspended t 5.5 mg/ml prtein. The prteins are detergent extracted and laded t within the linear range f the assay (see belw). A cntrl r nrmal sample shuld always be included in the assay as a reference. Als, include a null r buffer cntrl t act as a backgrund reference measurement. Typical linear ranges per well (50 µl) and per milliliter are listed belw. The ranges may be extended by using a nn-linear fit f the data frm a nrmal sample. Example Ranges: Bvine heart mitchndria 1-25 µg/well 20-500 µg/ml Whle cultured cell extract 4-250 µg/well 80-5000 µg/ml NOTE: Ranges fr tissue extract may vary slightly. The lwest amunt indicated is the lwest amunt tested (>2x backgrund). Fr sample lading use the recmmended amunt specified n page 3. Intra assay variatin = <15 % ADDITIONAL MATERIALS REQUIRED Spectrphtmeter plate reader (Mlecular Dynamics SpectraMax recmmended) capable f measuring absrbance at 600 nm. Methd fr determining prtein cncentratin Deinized water Multichannel pipette PBS (phsphate buffered saline) fr recipe see /PDF/western.pdf Page 2 f 9

COMPLEX II ACTIVITY ASSAY Nte: This prtcl cntains detailed steps fr measuring Cmplex II activity. Be cmpletely familiar with the prtcl befre beginning the assay. D nt deviate frm the specified prtcl steps r ptimal results may nt be btained. When ding multiple experiments it is recmmended t make nly prprtinally enugh wrking slutins and reagents frm the supplied cncentrated stcks. A. Sample preparatin 1. Prepare the buffer slutin by adding 15 ml f 20X buffer t 285 ml deinized H 2 O. Label this 1X Buffer slutin. Mix, stre in the refrigeratr. 2. Prepare the Incubatin slutin by adding 5 ml 10X Blcking Slutin t 45 ml 1X Buffer. Label this 1X Incubatin slutin. Mix, stre in the refrigeratr. 3. Resuspend sample tissue hmgenate, cell culture pellet, r mitchndria t 5.5 mg/ml in PBS. 4. Add 1/10 vlume f Detergent t the sample (e.g. if the ttal sample vlume is 500 μl, add 50 μl f Detergent). Therefre the final prtein cncentratin is 5 mg/ml. 5. Mix immediately and incubate fr 30 minutes n ice. 6. Centrifuge at 25,000 g fr 20 minutes at 4 C. Cllect the supernatant discard the pellet. B. Plate Lading 7. Dilute the sample in 1X Incubatin slutin, t the desired cncentratin per ml shwn in the table belw. Sample Type Recmmended amunt Whle cultured cell extract 60 µg/50 µl (1.2 mg/ml) Heart mitchndria 10 µg/50 µl (0.2 mg/ml) 8. Keep the diluted samples n ice until ready t begin. 9. Add 50 L f diluted sample per well. Be sure t include a nrmal r cntrl sample and als a buffer nly sample (1X Incubatin slutin). A dilutin series f a nrmal cntrl sample is als recmmended. 10. Cver the plate and incubate fr 2 hurs at rm temperature. C. Measurement 11. The bund mnclnal antibdy has immbilized the enzyme in the wells. Empty the wells by turning the plate ver and shaking ut any remaining liquid. 12. Once emptied, add 300 μl f 1X Buffer slutin t each well used. Page 3 f 9

13. Empty the wells again and add anther 300 μl f 1X Buffer slutin t each well used. 14. Empty the wells and add 40 µl f lipid slutin t each well used. Incubate 30 minutes. 15. Prepare the Activity slutin. Make nly enugh slutin prprtinal t the number f micrplate strips used. Use the fllwing table t calculate hw much slutin t make fr 1-12 micrplate strips used. N. f micrplate strips Ubiquinne 2 (µl) Succinate (µl) DCPIP (µl) 1 5 42 21 2.1 2 10 83 42 4.2 3 15 125 63 6.3 4 20 167 83 8.3 5 25 208 104 10.4 6 30 250 125 12.5 7 35 292 146 14.6 8 40 333 167 16.7 9 45 375 188 18.8 10 50 417 208 20.8 11 55 458 229 22.9 12 60 500 250 25 Activity buffer (ml) 16. D nt empty the wells; instead add 200 µl f Activity slutin (A15) t each well already cntaining 40 µl lipids fr a ttal f 240 µl. Any bubbles in the wells shuld be ppped with a fine needle as rapidly as pssible, begin micrplate reading using the fllwing parameters: Activity - Kinetic measurement OD 600 nm Rm temperature Time: 60 mins Interval: 20 sec - 1 min NO shake befre r between readings Save data and analyze as described in the DATA ANALYSIS sectin. Nte it is pssible t make an endpint measurement in place f kinetic measurement, but be sure t measure the endpint befre the mst active sample has begun t slw dwn (see example belw BHM sample >1600s). Page 4 f 9

DATA ANALYSIS COMPLEX II ACTIVITY The initial slutin fr the activity measurement shuld be blue in appearance with an OD f apprximately 0.2 mod units at 600 nm. The reductin f ubiquinne and subsequent reductin f DCPIP is measured as a decrease in absrbance at OD 600 nm (see Figure 1). Mnitr the rate f decrease in absrbance at 600 nm ver time. Calculate the rate between tw time pints fr all the samples where the decrease in absrbance is the mst linear (typically between 15 mins and 25 mins shwn belw). After 30 minutes the rate f reductin in absrbance may decline fr the mst active samples due lack f substrate s d nt calculate the rate after this pint. Rate (mod/min) = Absrbance 1 - Absrbance 2 Time (min) The activity f immuncaptured Cmplex II is the mean f measurements btained with immuncaptured enzyme minus the rate btained withut immuncaptured enzyme. Fr example, if the rates f immuncaptured Cmplex II are 3.2, 3.1 and 3.7 mod/min and the backgrund rate (null sample) is 0.1 mod/min, the activity f Cmplex II is (3.2+3.1+3.7)/3-0.1 which is 3.23 mod/min. Nw the activity f immuncaptured Cmplex II in between samples can be cmpared. Figure 1. Example f raw data. Nte the lag perid befre activity. Als nte the activity f mitchndria (BHM, bvine heart mitchndria) is higher than whle cell lysate (HepG2, human hepatblastma) and the reactin ends at >1600 secnds because the substrates are used up. This assay is cmpatible with different sample types such as mitchndria, tissue r cell lysates and in multiple species including human and rdent samples. Typical linear range data are shwn belw in Figure 2. Page 5 f 9

Figure 2. Data are mst easily interpred by wrking in the linear range f the assay as shwn here, hwever the range can als be extended by nn-linear curve fitting. Page 6 f 9

FLOW CHART Fr quick reference nly. Be cmpletely familiar with previus details f this dcument befre perfrming the assay. Prepare Sample (1-2 hurs) Bring sample t 5.5 mg/ml in PBS. Perfrm detergent extractin with 1/10 vlume detergent, 30 mins n ice, fllwed by 25,000 g centrifugatin fr 20 minutes at 4 C. Take supernatant. Adjust cncentratin t recmmended dilutin fr plate lading in Incubatin buffer. Lad Plate (2 hurs) Lad sample(s) n plate being sure t include psitive cntrl sample and buffer cntrl as a null reference. Incubate 2 hurs at rm temperature. Measure (1 hurs) Rinse wells twice with 1X Buffer. Add 40 μl f Lipid mix t wells Add 200 µl Activity slutin int the lipid mix in each well. Measure OD 600 at 1 minute intervals fr 1 hur at rm temperature with n plate shake functin. Page 7 f 9

MICROPLATE MS / / A B C D E F G H 1 2 3 4 5 6 7 8 9 10 11 12 MS241 Page 8 f 9

NOTES Sample preparatin is crucial t a successful analysis. Key parameters: Hmgenizatin Samples must be cmpletely hmgenus. Fr cultured cells this shuld nly require pipetting up and dwn t break apart clumps f cells. Similarly fr mitchndrial preparatins, pipetting is enugh t distribute the mitchndria evenly in slutin. Fr sft tissue, and especially fr hard tissues such as muscle, thrugh hmgenizatin must ccur. This is best accmplished with a hand held tissue grinder such as an electric Ultra Turrax T8 tissue grinder r a Dunce glass tissue grinder available frm MitSciences. It is recmmended t use ne f MitSciences Mitchndrial Islatin Kits (MS850- MS853). Sample slubilizatin It is mst cnvenient t resuspend t apprximately 10 mg/ml. Then determine the exact prtein cncentratin by BCA methd (Pierce). Then add slutin t a prtein cncentratin f 5.5 mg/ml in PBS. The sample can nw be extracted by adding 1/10 vlume f the supplied detergent. The final prtein cncentratin is nw 5 mg/ml, which is the ptimal cncentratin fr intact Cmplex II slubilizatin by the supplied detergent. The sample is incubated, centrifuged and supernatant (detergent extract) is cllected. Inhibitr sensitivity The enzyme is sensitive t 2-thenyltrifluracetne (TTFA) a specific inhibitr f Cmplex II with IC 50 f 30 µm. Page 9 f 9